Joe Biden
Speeding up efforts to develop a blood test for cancer was among more than 30 big projects that Vice President Joe Biden said would make up the “Cancer Moonshot” earlier this week.
Canton-based Personal Genome Diagnostics, which is built on pioneering cancer genomics research that was spun out of Johns Hopkins University, is one of the private-sector players involved in the effort to open up data about a liquid biopsy.
A test that only requires drawing one or two tubes of blood is seen as an improvement on the current tests for cancer, such as a traditional biopsy performed under surgery or an ultrasound scan. It’s less invasive and risky. The testing is also done at the genetic level, tracking how cancer mutates.
READ FULL ARTICLE HERE
